Apyx Medical Corp
Current role
APYX
Medical Devices · Healthcare
CEO, Board Member
2026-08-06–present
Charles D. Goodwin
Board Member
Apyx Medical Corp (APYX)Equibles does not estimate personal net worth.
Get an email with a short summary when Apyx Medical Corp publishes a filing, an earnings call transcript or a press release.
Get APYX alertsAbout Charles D. Goodwin
Charles D. Goodwin is recorded as Board Member at Apyx Medical Corp (APYX) since August 6, 2026 and CEO at Apyx Medical Corp (APYX). The newest filing on record that lists Charles D. Goodwin as CEO at Apyx Medical Corp (APYX) is dated June 26, 2026. Apyx Medical Corp reported in an 8-K filed August 7, 2026 that Charles D. Goodwin was appointed director, effective August 6, 2026. The proxy statement of Apyx Medical Corp reports total compensation of $1,233,863 for Charles D. Goodwin in fiscal 2025, including a base salary of $501,800. Disclosed compensation is on record for 9 fiscal years. Apyx Medical Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Apyx Medical Corp includes Charles Goodwin (CEO and Board Member), Stavros G. Vizirgianakis (Chairman and Board Member), Mathew Hill (CFO) and 7 others.
“The Company's stockholders elected each of the following five (5) directors to serve on the Board of Directors of the Company until the 2027 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, by the following vote:”
Affiliation history
-
Current
2026-08-06–present
-
Current
Start not stated–present
Last confirmed June 26, 2026
Company network
Leadership on record at Apyx Medical Corp
- Charles Goodwin CEO, Board Member
- Stavros G. Vizirgianakis Chairman, Board Member
- Mathew Hill CFO
- Matthew Hill CFO, Chief Accounting Officer, Board Member
- Shawn D. Roman COO
- Shawn Roman COO, Board Member
- Lawrence J. Waldman Board Member
- Minnie Baylor-Henry Board Member
- Moshe Citronowicz Board Member
- Stavros Vizirgianakis Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Apyx Medical Corp (APYX) | CEO and Director | $501,800 | $1,233,863 |
| 2024 | Apyx Medical Corp (APYX) | CEO and Director | $501,800 | $975,971 |
| 2023 | Apyx Medical Corp (APYX) | CEO and Director | $482,500 | $1,261,470 |
| 2022 | Apyx Medical Corp (APYX) | CEO and Director | $482,500 | $2,170,236 |
| 2021 | Apyx Medical Corp (APYX) | CEO and Director | $450,000 | $1,594,394 |
| 2020 | Apyx Medical Corp (APYX) | CEO and Director | $450,000 | $1,832,880 |
| 2019 | Apyx Medical Corp (APYX) | CEO and Director | $450,000 | $1,945,258 |
| 2018 | Apyx Medical Corp (APYX) | CEO and Director | $400,000 | $1,785,385 |
| 2017 | Apyx Medical Corp (APYX) | CEO and Director | $15,385 | — |